Patents by Inventor Amy H. Atzel

Amy H. Atzel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GSK3 ligands and polynucleotides encoding GSK3 ligands
    Patent number: 9315786
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands and polyligands that modulate GSK3 activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Grant
    Filed: April 17, 2014
    Date of Patent: April 19, 2016
    Assignee: Intrexon Corporation
    Inventors: Thomas D. Reed, Amy H. Atzel
  • mTOR ligands and polynucleotides encoding mTOR ligands
    Patent number: 9301992
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate mTOR activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Grant
    Filed: October 7, 2015
    Date of Patent: April 5, 2016
    Assignee: Intrexon Corporation
    Inventors: Thomas David Reed, Amy H. Atzel
  • mTOR Ligands and Polynucleotides Encoding mTOR Ligands
    Publication number: 20160022766
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate mTOR activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Application
    Filed: October 7, 2015
    Publication date: January 28, 2016
    Inventors: Thomas David REED, Amy H. Atzel
  • mTOR ligands and polynucleotides encoding mTOR ligands
    Patent number: 9181314
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate mTOR activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Grant
    Filed: June 25, 2015
    Date of Patent: November 10, 2015
    Assignee: Intrexon Corporation
    Inventors: Thomas David Reed, Amy H. Atzel
  • mTOR Ligands and Polynucleotides Encoding mTOR Ligands
    Publication number: 20150291676
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate mTOR activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Application
    Filed: June 25, 2015
    Publication date: October 15, 2015
    Applicant: Intrexon Corporation
    Inventors: Thomas David REED, Amy H. Atzel
  • mTOR ligands and polynucleotides encoding mTOR ligands
    Patent number: 9096680
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate mTOR activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Grant
    Filed: February 24, 2014
    Date of Patent: August 4, 2015
    Assignee: Intrexon Corporation
    Inventors: Thomas David Reed, Amy H. Atzel
  • PKC ligands and polynucleotides encoding PKC ligands
    Patent number: 8999666
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate PKC activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands, homopolyligands, and heteropolyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Grant
    Filed: August 9, 2007
    Date of Patent: April 7, 2015
    Assignee: Intrexon Corporation
    Inventors: Thomas D. Reed, Amy H. Atzel
  • GSK3 Ligands and Polynucleotides Encoding GSK3 Ligands
    Publication number: 20140273227
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands and polyligands that modulate GSK3 activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Application
    Filed: April 17, 2014
    Publication date: September 18, 2014
    Applicant: Intrexon Corporation
    Inventors: Thomas D. REED, Amy H. ATZEL
  • Glycogen synthase kinase heteropolyligand polypeptide
    Patent number: 8729225
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands and polyligands that modulate GSK3 activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Grant
    Filed: November 9, 2007
    Date of Patent: May 20, 2014
    Assignee: Intrexon Corporation
    Inventors: Thomas David Reed, Amy H. Atzel
  • mTOR ligands and polynucleotides encoding mTOR ligands
    Patent number: 8679784
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate mTOR activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Grant
    Filed: June 7, 2012
    Date of Patent: March 25, 2014
    Assignee: Intrexon Corporation
    Inventors: Thomas David Reed, Amy H. Atzel
  • mTOR Ligands and Polynucleotides Encoding mTOR Ligands
    Publication number: 20130244329
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate mTOR activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Application
    Filed: June 7, 2012
    Publication date: September 19, 2013
    Applicant: Intrexon Corporation
    Inventors: Thomas David REED, Amy H. Atzel
  • mTOR ligands and polynucleotides encoding mTOR ligands
    Patent number: 8211669
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate mTOR activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Grant
    Filed: February 17, 2010
    Date of Patent: July 3, 2012
    Assignee: Intrexon Corporation
    Inventors: Thomas David Reed, Amy H. Atzel
  • mTOR Ligands and Polynucleotides Encoding mTOR Ligands
    Publication number: 20100257619
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate mTOR activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Application
    Filed: February 17, 2010
    Publication date: October 7, 2010
    Applicant: Intrexon Corporation
    Inventors: Thomas David REED, Amy H. Atzel
  • mTOR ligands and polynucleotides encoding mTOR ligands
    Patent number: 7705122
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate mTOR activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Grant
    Filed: November 30, 2007
    Date of Patent: April 27, 2010
    Assignee: Intrexon Corporation
    Inventors: Thomas David Reed, Amy H. Atzel
  • mTOR LIGANDS AND POLYNUCLEOTIDES ENCODING mTOR LIGANDS
    Publication number: 20080220475
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate mTOR activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Application
    Filed: November 30, 2007
    Publication date: September 11, 2008
    Inventors: Thomas David Reed, Amy H. Atzel
  • GSK3 LIGANDS AND POLYNUCLEOTIDES ENCODING GSK3 LIGANDS
    Publication number: 20080213834
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands and polyligands that modulate GSK3 activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Application
    Filed: November 9, 2007
    Publication date: September 4, 2008
    Inventors: Thomas David Reed, Amy H. Atzel